BioreclamationIVT is now BioIVT

YOUR PARTNER IN ELEVATING SCIENCE

BioIVT, formerly BioreclamationIVT, is a leading global provider of high-quality biological specimens and value-added services. We specialize in control and disease state samples including human and animal tissues, cell products, blood and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples. 

Our PHASEZERO Research Services team works collaboratively with clients to provide target and biomarker validation, phenotypic assays to characterize novel therapeutics, clinical assay development and in vitro hepatic modeling solutions. And as the world’s premier supplier of ADME-Tox model systems, including hepatocytes and subcellular fractions, BioIVT enables scientists to better understand the pharmacokinetics and drug metabolism of newly discovered compounds and the effects on disease processes. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE.

Learn about the new BioIVT!
BioIVT Corporate Video

VIEW OUR PRODUCTS AND SERVICES

BioIVT is a worldwide provider of human and animal biological specimens and value-added services to pharmaceutical, biotechnology, diagnostic, contract research organizations (CRO),  academic and government institutions.

Looking for a Product or Service?

Our new site has over 400 individual product pages featuring the complete capabilities of BioIVT.

Visit our Request A Quote page to learn how to find your product or service of interest.

FROM THE BLOG

Cell-based Assays: A Crucial Component of the Drug Discovery Process

By Alesha Grant, Ph.D. / July 20, 2018

Why Utilize Cell-based Assays? Cell-based assays streamline the drug discovery and development process, implementation can help avoid costly toxicity and efficacy issues that may arise at later phases of clinical trials.  Cell-based assays provide invaluable biological information about cellular processes, cellular viability, drug mechanisms of action, and off-target effects. The global market for cell-based assays… Read more »

Read More >